Augmedix, Inc. (AUGX) NASDAQ

2.35

-0.005(-0.21%)

Updated at October 01, 2024 03:57PM

Currency In USD

Valuation

Market Cap257.09M
Enterprise Value236.59M
P/E Ratio-5.38
PEG Ratio-0.05
Price/Sales Ratio2.58
Price/Book Ratio4.42
Enterprise/Revenue2.13
Enterprise/EBITDA-5.4

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-0.43
Operating Margin-0.42

Management Effectiveness

Return On Assets-0.29
Return On Equity-1.55

Income Statement

Revenue44.86M
Revenue/Share1.02
Gross Profit21.53M
EBITDA-15.68M
Net Income-19.17M
Diluted EPS-0.44

Balance Sheet

Total Cash28.22M
Total Cash/Share1.05
Total Debt26.71M
Total Debt/Equity1.11
Current Ratio2.41
Book Value Per Share0.53

Price History

52-Week Change-46.7
52-Week High6.25
52-Week Low0.73
Moving Average 50 Days2.29
Moving Average 200 Days3.01

Statistics

Average Volume808,771
Shares Outstanding49.43M
% Held by Institutions67.19

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A